Sometimes two heads are better than one. That's the case when it comes to the PA/Physician team of Dr. Laurie Benton PA-C and her supervisor Dr. Charles Foulks. The two working together over the years have been able to slow the progression of kidney disease and keep their patients off dialysis. Dr. Foulks, medical officer at the University of Oklahoma College of Medicine in Tulsa, Oklahoma and Dr. Benton an orthopedic hospitalist joins host, Lisa D'Andrea Lenell to talk about the keys to a successful PA/Doctor team.
A Conversation with the PA/Physician Team of the Year
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Details
Presenters
Overview
Sometimes two heads are better than one. That's the case when it comes to the PA/Physician team of Dr. Laurie Benton PA-C and her supervisor Dr. Charles Foulks. The two working together over the years have been able to slow the progression of kidney disease and keep their patients off dialysis. Dr. Foulks, medical officer at the University of Oklahoma College of Medicine in Tulsa, Oklahoma and Dr. Benton an orthopedic hospitalist joins host, Lisa D'Andrea Lenell to talk about the keys to a successful PA/Doctor team.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
1.00 credits
<p>I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis</p>
MinuteCE®
M3: Managing the Cardiometabolic Risk in MASH
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">M3: Managing the Cardiometabolic Risk in MASH</span><span data-ccp-props='{"201341983":0,"335559739":160,"335559740":259}'> </span></p>
Perspectives with the AMA
Implementing the AMA MAPTM Hypertension Program: A Clinician’s Experience
<p>Implementing the AMA MAP™ Hypertension Program: A Clinician's Experience</p>
MinuteCE®
The Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality
0.50 credits
<p>The Heart’s Aftermath: IRI’s Impact on Cardiac Morbidity & Mortality</p>
MinuteCE®
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
1.25 credits
<p>Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer</p>
MinuteCE®
Immunotherapy for TNBC in the Perioperative Setting: Clinical Evidence and Considerations
1.50 credits
<p>Immunotherapy for TNBC in the Perioperative Setting: Clinical Evidence and Considerations</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
NeuroFrontiers
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
<p>MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?